TOI

TOI

Oncology Institute Inc

Net 28.20%top 1%Rev 8.56%top 1%Net income grew 100% of yearsRevenue grew 100% of years1Y
Hold

Oncology Institute Inc provides comprehensive oncology services in the U.S., including specialty pharmacy, clinical trials, radiation therapy, and patient support. It operates community clinics and infusion centers, serving adult and senior cancer patients.

โš•๏ธ Healthcare NASDAQ Listed 2021 $ USD
$1,000 invested 5 years ago โ†’$516today

Score Overview

1 Year
Scoreโ€”
Net Growth28.20%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth8.56%
Rev TrendGrew
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-298.22%
Net Trend80%
Net Income Consistency
Rev Growth168.85%
Rev TrendEvery year
Revenue Consistency

See the full market ranking โ†’

Oncology Institute Inc fundamental performance

Across Oncology Institute Inc's full reported history, from 2021 to 2025, revenue grew from $ 203M to $ 502M and net income went from -$ 10M to -$ 60M. Revenue increased in 100% of the years measured; net income in 80%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-03
$ 5.13โ€”
1 Year2025-08-13
$ 4.1025.12%
5 Years2021-08-13
$ 9.94-48.39%
All Time2021-11-15
$ 9.77-47.49%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 545M-$ 43M$ 30M
2025$ 502M-$ 60M$ 33M
2024$ 393M-$ 64M$ 49M
2023$ 324M-$ 83M$ 82M
2022$ 252M$ 152K$ 73M
IPO2021$ 203M-$ 10M$ 114M

Explore beyond TOI

You're looking at Oncology Institute Inc. Members apply the same fundamental framework across all 3,859 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies